Early ventricular assist devices were frequently compromised by hemolysis and thrombosis until
The discrepancy between high denial rates and successful appeals indicates that missing
Medical professionals are documenting surprising improvements in arthritis symptoms and joint mobility that appear entirely independent of a patient's actual weight loss. This unexpected therapeutic success has shifted the clinical narrative surrounding glucagon-like peptide-1 receptor agonists
Providing a cohesive member experience requires the elimination of silos between primary health navigation and specialized clinical departments. In the current medical environment of 2026, patients often face a disjointed journey when moving from their primary care physician to a specialist,
The immunotherapy revolution is fundamentally reshaping the treatment landscape for liver cancer by
Province-wide tools like CareConnect provide a secondary safety net, but physicians note these
A clinician spends nearly two hours on documentation for every hour of direct patient care. This ratio reflects the broader operational pressures that health systems face as demand grows and…
Oncology does not have a data problem. It has a decision latency problem that keeps insights
Most public health models explain yesterday's outbreak. Leaders need systems that flag risk
Biotech and pharma sponsors struggle when dose decisions are made late, rest on narrow evidence, or
Each patient generates over 1,300 data points daily in modern intensive care units. This data surge
Minnesota's status as a premier medical technology hub faces a test as its largest manufacturing players transition to private equity management. The recent move by KKR to acquire Integer Holdings for $5.7 billion represents more than just a financial transaction; it signifies a tectonic shift in
The Food and Drug Administration recently reaffirmed the safety of fluoropolymers after reviewing
The discrepancy between high denial rates and successful appeals indicates that missing
